COVID-19 Vaccine Shipped, and Drug Trials Start

Moderna Therapeutics, a biotech company based in Cambridge, Mass., has shipped the first batches of its COVID-19 vaccine. The vaccine was created just 42 days after the genetic sequence of the COVID_19 virus, called SARS-CoV-2, was released by Chinese researchers in mid-January. The first vials were sent to the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) in Bethesda, MD, which will ready the vaccine for human testing as early as April. NIH scientists also began testing an antiviral drug called remdesivir that had been developed for Ebola, on a patient infected with SARS-CoV-2. The trial is the first to test a drug for treating COVID-19, and will be led by a team at the University of Nebraska Medical Center. The first patient to volunteer for the ground-breaking study is a passenger who was brought back to the US after testing positive for the disease aboard the Diamond Princess. Others diagnosed with COVID-19 who have been hospitalized will also be part of the study. Remdesivir showed encouraging results among animals infected with two related coronaviruses, one responsible for severe acute respiratory syndrome (SARS) and another for causing Middle East respiratory syndrome (MERS). Volunteers will be randomly assigned to receive either the drug or a placebo intravenously for 10 days, and they will have blood tests and nose and throat swabs taken every two days to track the amount of virus in their bodies. Eve...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news

Related Links:

(1) Background: Older people are more vulnerable and likely to have falls and the consequences of these falls place a heavy burden on individuals, families and society. Many factors directly or indirectly affect the prevalence of falls. The aims of this st...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
BACKGROUND: Workplace violence against healthcare workers is a global issue that is on the rise, with Chinese healthcare workers facing growing challenges with hospital violence. Attacks on medical staff have increased in recent years with no clear resolut...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Occupational Issues Source Type: news
As the number of COVID-19 cases increases, UR Medicine and Rochester Regional Health will implement “universal masking” on March 31 to help slow the spread of the virus.
Source: University of Rochester Medical Center Press Releases - Category: Universities & Medical Training Authors: Source Type: news
Governor Newsom Announces California Health Corps, a Major Initiative to Expand Health Care Workforce to Fight COVID-19 | California Governor Governor signs executive order to expand health care workforce and staff at least an additional 50,000 hospital beds needed for the COVID-19 surge Medical doctors, nurses, respiratory therapists… www.gov.ca.gov Any idea on what the role will be ?
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Medical Students - MD Source Type: forums
radRounds Radiology Network and Idonia are partnering to provide a professional Image Exchange Platform to facilitate collaboration, exchange and research on COVID-19 cases.Users can upload, store, organize, review, and share DICOM Images.Idonia is a secure (HIPAA compliant) online platform for medical image exchange and delivery. The platform can serve as a repository for relevant clinical cases, which radiologists can access and visualize thanks to the DICOM viewer of the platform. This allows radiologists to create their own network to collaborate and share relevant cases with other radiologists.Idonia and radRounds hav...
Source: radRounds - Category: Radiology Authors: Source Type: blogs
There is an urgent need to share expertise and offer emergency guidance for breast radiation therapy (RT) during the COVID-19 (Coronavirus) pandemic. As per the World Health Organisation (WHO) statement, our aim and obligation should be “to stop, contain, control, delay and reduce the impact of this virus at every opportunity”. In our roles as healthcare professionals and/or breast cancer experts this translates to minimising exposure of our patients to COVID-19 without compromising oncological outcome.
Source: Clinical Oncology - Category: Radiology Authors: Tags: Editorial Source Type: research
A Cuba-born man who practiced as a radiologist in Paraguay has become the first...Read more on AuntMinnie.comRelated Reading: CT confirms bathhouse transmission of SARS-CoV-2 RSNA launches online resource for COVID-19 Quality Payment Program modified due to COVID-19 outbreak SNMMI creates online COVID-19 info center Former GE medical head Walter Robb dies of COVID-19
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
President Donald Trump’s declaration of a national emergency is designed to speed federal support to parts of America that are struggling to prepare for a coming surge of COVID-19 cases, unlocking $50 billion in aid, giving hospitals and doctors more freedom to handle a potential tsunami of sick patients and scrambling to make tests available. In a Rose Garden press conference Friday, Trump presented the emergency measures as proof that, “No nation is more prepared or more equipped to face down this crisis.” But for epidemiologists, medical experts and current and former U.S. public health officials, the ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
This study, says Kalil, is also designed to be more flexible than most drug trials. “This is not just a remdesivir trial,” he says. “It will test as many [COVID-19] therapies as possible, and remdesivir is just the first. Let’s say a couple of months from now, we realize that remdesivir is a good drug, that it works better than placebo…. Then patients receiving the placebo would be offered the drug and we would move on to test another drug. If remdesivir turns out not to be effective, then we would remove it from the study and bring another drug to test against placebo. It’s a dynamic, ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Infectious Disease Source Type: news
Cases of a novel pneumonia-like illness that originated in Wuhan, China in December have now been confirmed in South Korea, Thailand, Japan, Taiwan, Macau—and, as of Jan. 21, the U.S. The virus’ geographic reach, as well as its newly discovered ability to spread via person-to-person contact, has health officials worried about the prospect of globals spread. As health officials scramble to learn more about the virus and is origins, researchers are simultaneously turning to the question of how to develop a vaccine or therapy that could help contain transmission worldwide—a feat that experts say is technical...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Infectious Disease Source Type: news
More News: Allergy | Allergy & Immunology | Biology | Biotechnology | China Health | Coronavirus | COVID-19 | Ebola | Ebola Vaccine | ENT & OMF | Genetics | Health | Infectious Diseases | MERS | Middle East Health | National Institutes of Health (NIH) | Respiratory Medicine | SARS | Study | Vaccines | Veterinary Vaccinations | Wuhan Coronavirus